Biofourmis nets $300

Biofourmis, a provider of virtual care and digital medicine, has secured $300 million in Series D funding.

26 April 2022

Biofourmis, a provider of virtual care and digital medicine, has secured $300 million in Series D funding. General Atlantic led the round.

Register now

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Not for publication, email or dissemination